P.E.I. suspends use of AstraZeneca vaccine for those younger than 55 - CTV News Atlantic | Canada News Media
Connect with us

Business

P.E.I. suspends use of AstraZeneca vaccine for those younger than 55 – CTV News Atlantic

Published

 on


HALIFAX —
The province of Prince Edward Island has suspended use of the AstraZeneca COVID-19 vaccine for people under the age of 55.

Early Monday afternoon, a senior government source confirmed to CTV News that the NACI will recommend pausing administration of the AstraZeneca coronavirus vaccine to those under the age of 55.

In a live COVID-19 update later in the afternoon, P.E.I.’s chief public health officer, Dr. Heather Morrison announced the province would hault AstraZeneca doses for that age group as well.

“The term given to this presentation is called the VIPIT, vaccine induced pro thrombotic immune thrombocytopenia,” said Dr. Morrison. “Serious side effects from vaccines are very rare and VIPIT is a rare presentation occurring anywhere from one in every 125,000 to one in a million people. It’s important to note that no such blood clotting abnormalities or VIPIT have been reported in Canada.”

“This pause will allow the manufacturer to conduct a detailed assessment of the benefits and risk of the vaccine by age and gender in the Canadian context, its information along with further international evidence will be used to determine if additional regulatory actions are necessary,” Morrison added.

P.E.I. Premier Dennis King added assurance to those who have already received the AstraZeneca vaccine on the island.

“For those Islanders who have been vaccinated, to date using AstraZeneca, 1680 of them. I understand this news would be a little bit disturbing to hear this,” said King. “But, I do want to reiterate and Dr. Morrison will further reiterate that the risk of developing a serious problem after being immunized is very very low. To date there have been no reported cases of any of these issues in P.E.I., or Canada.”

King says all islanders will still be able to receive at least one dose of COVID-19 vaccine by the end of June.

The new federal recommendation is expected to be made official later Monday.

Several provinces have already announced plans in line with this expected recommendation, P.E.I. being the first.

Manitoba and Quebec announced later in the day that they were halting vaccinations using AstraZeneca doses for anyone under the age of 55.

Earlier Monday, P.E.I. spokesperson Samantha Hughes sent the following information to CTV News in an email, indicating they would hault AstraZeneca shots for those 18-29:

“Appointments at pharmacies for AstraZeneca vaccine for those 18-29 are on hold pending anticipated further information from Health Canada and NACI. We expect more information on this later today.”

Last Tuesday, Health Canada said the AstraZeneca COVID-19 vaccine is safe and will continue to be recommended for use despite criticism from U.S. health officials of the drugmaker’s analysis of the shot’s efficacy, health officials said.

“The message is that the efficacy and the safety of the vaccine have been shown,” senior Health Canada official Marc Berthiaume told reporters on March 23. “It continues to be beneficial for Canadians to prevent COVID-19.”

In early March, Denmark and other European countries suspended the use of the AstraZeneca vaccine after reports of blood clots. Norway and Sweden also have paused the use of the AstraZeneca vaccine.

Also on Tuesday, Dr. Heather Morrison, P.E.I.’s chief medical officer said most of the 2,000 doses of the AstraZeneca vaccine received on the island had been administered to people 18-29 working in the service industry, and reaffirmed Health Canada’s stance on the Astrazeneca vaccine, saying it is safe and effective, and encouraging any islanders who are offered it, to take it.

“I ask employers and business owners in these areas to encourage their staff age 18-29 to be immunized,” said Morrison on March 23. “And, if possible, please offer to assist with transportation and eliminating any other barriers that may be preventing staff from being vaccinated.”

The province had expanded the AstraZeneca eligibility to any 18-29 year olds who cannot work virtually. Initially the vaccines were opened to 18-29 year olds who work in the food and beverage sector.

This is a developing story. It will be updated throughout the day.

Let’s block ads! (Why?)



Source link

Continue Reading

Business

Roots sees room for expansion in activewear, reports $5.2M Q2 loss and sales drop

Published

 on

 

TORONTO – Roots Corp. may have built its brand on all things comfy and cosy, but its CEO says activewear is now “really becoming a core part” of the brand.

The category, which at Roots spans leggings, tracksuits, sports bras and bike shorts, has seen such sustained double-digit growth that Meghan Roach plans to make it a key part of the business’ future.

“It’s an area … you will see us continue to expand upon,” she told analysts on a Friday call.

The Toronto-based retailer’s push into activewear has taken shape over many years and included several turns as the official designer and supplier of Team Canada’s Olympic uniform.

But consumers have had plenty of choice when it comes to workout gear and other apparel suited to their sporting needs. On top of the slew of athletic brands like Nike and Adidas, shoppers have also gravitated toward Lululemon Athletica Inc., Alo and Vuori, ramping up competition in the activewear category.

Roach feels Roots’ toehold in the category stems from the fit, feel and following its merchandise has cultivated.

“Our product really resonates with (shoppers) because you can wear it through multiple different use cases and occasions,” she said.

“We’ve been seeing customers come back again and again for some of these core products in our activewear collection.”

Her remarks came the same day as Roots revealed it lost $5.2 million in its latest quarter compared with a loss of $5.3 million in the same quarter last year.

The company said the second-quarter loss amounted to 13 cents per diluted share for the quarter ended Aug. 3, the same as a year earlier.

In presenting the results, Roach reminded analysts that the first half of the year is usually “seasonally small,” representing just 30 per cent of the company’s annual sales.

Sales for the second quarter totalled $47.7 million, down from $49.4 million in the same quarter last year.

The move lower came as direct-to-consumer sales amounted to $36.4 million, down from $37.1 million a year earlier, as comparable sales edged down 0.2 per cent.

The numbers reflect the fact that Roots continued to grapple with inventory challenges in the company’s Cooper fleece line that first cropped up in its previous quarter.

Roots recently began to use artificial intelligence to assist with daily inventory replenishments and said more tools helping with allocation will go live in the next quarter.

Beyond that time period, the company intends to keep exploring AI and renovate more of its stores.

It will also re-evaluate its design ranks.

Roots announced Friday that chief product officer Karuna Scheinfeld has stepped down.

Rather than fill the role, the company plans to hire senior level design talent with international experience in the outdoor and activewear sectors who will take on tasks previously done by the chief product officer.

This report by The Canadian Press was first published Sept. 13, 2024.

Companies in this story: (TSX:ROOT)

The Canadian Press. All rights reserved.

Source link

Continue Reading

Business

Talks on today over HandyDART strike affecting vulnerable people in Metro Vancouver

Published

 on

 

VANCOUVER – Mediated talks between the union representing HandyDART workers in Metro Vancouver and its employer, Transdev, are set to resume today as a strike that has stopped most services drags into a second week.

No timeline has been set for the length of the negotiations, but Joe McCann, president of the Amalgamated Transit Union Local 1724, says they are willing to stay there as long as it takes, even if talks drag on all night.

About 600 employees of the door-to-door transit service for people unable to navigate the conventional transit system have been on strike since last Tuesday, pausing service for all but essential medical trips.

Hundreds of drivers rallied outside TransLink’s head office earlier this week, calling for the transportation provider to intervene in the dispute with Transdev, which was contracted to oversee HandyDART service.

Transdev said earlier this week that it will provide a reply to the union’s latest proposal on Thursday.

A statement from the company said it “strongly believes” that their employees deserve fair wages, and that a fair contract “must balance the needs of their employees, clients and taxpayers.”

This report by The Canadian Press was first published Sept. 12, 2024.

The Canadian Press. All rights reserved.

Source link

Continue Reading

Business

Transat AT reports $39.9M Q3 loss compared with $57.3M profit a year earlier

Published

 on

 

MONTREAL – Travel company Transat AT Inc. reported a loss in its latest quarter compared with a profit a year earlier as its revenue edged lower.

The parent company of Air Transat says it lost $39.9 million or $1.03 per diluted share in its quarter ended July 31.

The result compared with a profit of $57.3 million or $1.49 per diluted share a year earlier.

Revenue in what was the company’s third quarter totalled $736.2 million, down from $746.3 million in the same quarter last year.

On an adjusted basis, Transat says it lost $1.10 per share in its latest quarter compared with an adjusted profit of $1.10 per share a year earlier.

Transat chief executive Annick Guérard says demand for leisure travel remains healthy, as evidenced by higher traffic, but consumers are increasingly price conscious given the current economic uncertainty.

This report by The Canadian Press was first published Sept. 12, 2024.

Companies in this story: (TSX:TRZ)

The Canadian Press. All rights reserved.

Source link

Continue Reading

Trending

Exit mobile version